Mrs. Zhang received her L.L.B degree from Beijing Forestry University in the year 2012 and later obtained her postgraduate degree (L.L.M) on international business direction from University of Montreal in the year 2013.

Mrs. Zhang specializes in Securities and Capital Market, Private Equity and Venture Capital, Mergers and Acquisitions, Company Compliance and Perennial Legal Services, and she was ranked as “30 Under 30” by LEGALBAND in 2019.

Mrs. Zhang has extensive experience in Medical, Film and Television, Education and TMT legal affairs. In the area of Securities and Capital Market, she has represented in and dealt with a number of well-known companies in the industry to provide legal services in the overseas listing projects of NASDAQ and HKEx, as well as the follow-up financing and acquisition business. Typical cases include AK Medical (HK. 1789), IVD Medical (HK. 1931), SINCO pharmaceutical (HK. 6833), China Kepei (HK. 1890), WAFU Education (NASDAQ: WAF), and China Index (NASDAQ：CIH), International Alliance (HK.1563), Qilu Expressway (HK.1576), etc.

In the area of Securities and Capital Market, Mr. Zhang has provided a wide range of legal services for many PE investment funds including Morgan Stanley, OrbiMed，LYFE Capital, Medtronic, New Horizon Capital, Entertainment Factory, multinational companies and industry leaders to carry out trans-border M & A or PE investment transactions, including conducting due diligence, designing transaction structure, participating in negotiation, drafting legal documents and issuing legal opinions.

Mrs. Zhang has PRC legal qualification.              

Mrs. Zhang is a native mandarin speaker with English fluency.

Represented AK Medical Holdings Limited on its restructuring and IPO on the main board of the HKEx (HK.1789)

Represented IVD Medical Holdings Limited on its restructuring and IPO on the main board of the HKEx (HK.1931)

Represented China Kepei Education Group Limited on its restructuring and IPO on the main board of the HKEx (HK.1890)

Represented Zhongtai International in the restructuring and IPO on the main board of the HKEx of Qilu Expressway Company Limited (HK. 1576)

Represented China Index Holdings Ltd on its restructuring and IPO on the NASDAQ Stock Market (NASDAQ：CIH)

Represented Wah Fu Education Group Ltd on its restructuring and IPO on the NASDAQ Stock Market (NASDAQ：WAF)

Represented Senico Healthcare on its series A and B equity financing from OrbiMed，LYFE Capital, Medtronic

Represented J.Q Pictures on its series A 、B and C equity financing from Delta Capital，CCBI, Zhongrong Capital

Represented Er Dong Pictures on its series A and A+ equity financing from Maoyan Entertainment, Emperor Entertainment, Pusi Capital

Represented China Kepei Education Group Limited on its acquiring of Harbin Insitute of Petroleum

• Analysis of regulations for approval of digital therapeutics
• FAQ: listing of biotech companies on the HKEX under Chapter 18A
• Investing in the "beauty economy"